Identifying HER2 from serum‐derived exosomes in advanced gastric cancer as a promising biomarker for assessing tissue HER2 status and predicting the efficacy of trastuzumab‐based therapy.
Autor: | Li, Qian1 (AUTHOR), Lv, Minzhi2 (AUTHOR), Lv, Lihua3 (AUTHOR), Cao, Nida4 (AUTHOR), Zhao, Aiguang4 (AUTHOR), Chen, Jiayan5 (AUTHOR), Tang, Xi5 (AUTHOR), Luo, Rongkui6 (AUTHOR), Yu, Shan1 (AUTHOR), Zhou, Yan3 (AUTHOR), Cui, Yuehong1 (AUTHOR), Guo, Wei1,7 (AUTHOR) guo.wei@zs‐hospital.sh.cn, Liu, Tianshu1 (AUTHOR) liu.tianshu@zs‐hospital.sh.cn |
---|---|
Zdroj: | Cancer Medicine. Feb2023, Vol. 12 Issue 4, p4110-4124. 15p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |